The Prevalence of Using Traditional, Complementary, and Integrative Medicine by Patients with Epidermolysis Bullosa
Using TCIM among EB patients
,
Abstract
Epidermolysis bullosa (EB) is an inherited disease that causes widespread symptoms characterized by extreme epithelial fragility. This study examined traditional, complementary, and integrative medicine (TCIM) usage among EB patients referred to clinics at Shiraz University of Medical Sciences between 2019 and 2020. We enrolled the patients with EB whose diseases were approved by a dermatologist and registered in the dermatology department and Molecular Dermatology Research Center affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. A researcher-made data gathering form, including knowledge, beliefs, practice, and the experience of the safety of TCIM, was used to collect the data. Interviews were done by phone calls, and oral consent was obtained from patients or their parents. Overall, 68 patients were included in this study. In this regard, 79.4% of the patients used TCIM by themselves or their families to manage EB. Approximately, half of the patients were not aware of the effects of the herbal medicines they used. Among medicinal plants, chicory (20.6%), thyme (16.2%), and Persian cornflower (14.7%) had the most consumption. More than half of these patients believed that medicinal plants were a less harmful treatment, and 48.5% considered them effective. In conclusion, the study revealed high medicinal plant usage among EB patients, but limited knowledge about their effectiveness. Public awareness about the benefits and risks of these remedies needs to be increased.
Has C, Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes. Exp Dermatol 2019;28:1146-1152.
Bonamonte D, Filoni A, De Marco A, Lospalluti L, Nacchiero E, et al. Squamous cell carcinoma in patients with inherited epidermolysis bullosa: review of current literature. Cells 2022;11:1365.
Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014;70:1103-1126.
Gonzalez ME. Evaluation and treatment of the newborn with epidermolysis bullosa. Semin Perinatol 2013;37:32-39.
Haynes L. Nutrition for children with epidermolysis bullosa. Dermatol Clin 2010;28:289-301.
Chogani F, Parvizi MM, Murrell DF, Handjani F. Assessing the quality of life in the families of patients with epidermolysis bullosa: the mothers as main caregivers. Int J Womens Dermatol 2021;7:721-726.
Parvizi MM, Nasrin S, Parvizi Z. Butterfly patients in Iran waiting to specific attention from authorities. Iran J Public Health 2017;46:1005-1006.
Santi CG, Gripp AC, Roselino AM, Mello DS, Gordilho JO, et al. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. An Bras Dermatol 2019;94:33-47.
Hsu CK, Wang SP, Lee JY, McGrath JA. Treatment of hereditary epidermolysis bullosa: updates and future prospects. Am J Clin Dermatol 2014;15:1-6.
Saki N, Vahedi S, Parvizi MM, Shafie'ei M, Hosseini SA, et al. Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double‐blind, split‐site, randomized controlled trial. Dermatol Ther 2022;35:e15767.
Narlou MG, Sharif MP. Anthropological study of the use of medicinal plants in traditional medicine Case study (Mahallat city) 2017.
Yeo GE, Law JX. Regenerative medicine for neonatal wound healing. Curr Chin Sci 2022;2:160-167.
Tulunay M, Aypak C, Yikilkan H, Gorpelioglu S. Herbal medicine use among patients with chronic diseases. J Intercult Ethnopharmacol 2015;4:217-220.
Parvizi MM, Fatehi N, Jaladat AM, Gholampour Z, Shahriarirad R, et al. Epidemiological factors in patients with dermatologic conditions referring to the clinic of traditional persian medicine: a cross‐sectional study. Int J Clin Pract 2021;75:e14788.
Bordbar M, Pasalar M, Safaei S, Zareifar S, Haghpanah S. Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study. J Tradit Complement Med 2018;8:141-146.
Bordbar M, Pasalar M, Aresehiri R, Haghpanah S, Zareifar S, et al. A cross-sectional study of complementary and alternative medicine use in patients with coagulation disorders in Southern Iran. J Integr Med 2017;15:359-364.
Kim S, Chang L, Weinstock-Guttman B, Gandhi S, Jakimovski D, et al. Complementary and alternative medicine usage by multiple sclerosis patients: results from a prospective clinical study. J Altern Complement Med 2018;24:596-602.
Dastgheib L, Farahangiz S, Adelpour Z, Salehi A. The prevalence of complementary and alternative medicine use among dermatology outpatients in Shiraz, Iran. J Evid-Based Complement Altern Med 2017;22:731-735.
Landis ET, Davis SA, Feldman SR, Taylor S. Complementary and alternative medicine use in dermatology in the United States. J Altern Complement Med 2014;20:392-398.
Jackson BP. Herbal drugs and phytopharmaceuticals: A handbook for practice on a scientific basis, edited and translated from the second German edition by Norman Grainger Bisset, London; German edition edited by Max Wichtl, Marburg. With a foreword by J. David Phillipson, Medpharm Scientific Publishers. Stuttgart 1994 pp 377-379.
Wölbling RH, Leonhardt K. Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine 1994;1:25-31.
Ajmeer AS, Dudhamal TS, Gupta SK, Mahanta V. Topical application of Katupila (Securinega leucopyrus) in Dushta Vrana (chronic wound) showing excellent healing effect: A case study. Ayu 2014;35:175-178.
Murat-Sušić S, Husar K, Skerlev M, Marinović B, Babić I. Inherited epidermolysis bullosa - the spectrum of complications. Acta Dermatovenerol Croat 2011;19:255-263.
Niazi M, Parvizi MM, Saki N, Parvizi Z, Mehrbani M, et al. Efficacy of a topical formulation of henna (lawsonia inermis linnaeus) on the itch and wound healing in patients with epidermolysis bullosa: a pilot single-arm clinical trial. Dermatol Pract Concept 2022;12:e2022115.
Fattahi MR, Alorizi SME, Nimrouzi M, Zarshenas MM, Parvizi MM. A randomized clinical trial on treatment of chronic constipation by traditional persian medicine recommendations compared to allopathic medicine: A pilot study. Int J Prev Med 2017;8:50.
Barimani S, Nimrouzi M, Daryani NE, Karimi M, Heydari ST, et al. The efficacy of a persian medicine formulation on adult functional constipation: a double-blinded clinical trial. Shiraz E-Med J 2020;22:e101785.
Nimrouzi M, Sadeghpour O, Imanieh MH, Ardekani MS, Salehi A, et al. Flixweed vs. polyethylene glycol in the treatment of childhood functional constipation: a randomized clinical trial. Iran J pediatr 2015;25:e425.
Emami Alorizi SM, Fattahi MR, Saghebi SA, Salehi A, Rezaeizadeh H, et al. Assessment of the impacts of traditional Persian medical schemes and recommendations on functional chronic constipation compared to a classic medicine lactulose, a randomized clinical trial. J Complement Integr Med 2015;12:325-331.
Peltzer K, Pengpid S. The use of herbal medicines among chronic disease patients in Thailand: a cross-sectional survey. J Multidiscip Healthc 2019;12:573-582.
El-Dahiyat F, Rashrash M, Abuhamdah S, Abu Farha R, Babar Z-U-D. Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults. J pharm Policy Pract 2020;13:2.
Pearson H, Fleming T, Chhoun P, Tuot S, Brody C, et al. Prevalence of and factors associated with utilization of herbal medicines among outpatients in primary health centers in Cambodia. BMC Complement Altern Med 2018;18:114.
Abdelmola AO, Bahri A, Abuallut I, Refaei BA, Hakami WK, et al. Prevalence, knowledge, and perception about the use of herbal medicines jazan-Saudi Arabia. J Fam Med Prim Care 2021;10:2386.
| Issue | Vol 9, No 4, 2024 -In Press- | |
| Section | Research Article(s) | |
| Keywords | ||
| Epidermolysis Bullosa Traditional medicine Complementary therapies Herbal medicine Persian medicine | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
